Decision Diagnostics Corp (DECN)

[loanranger]

The Management Discussion and Supplemental Disclosures that were originally filed have already been rendered inactive. Click the Inactive button:
https://www.otcmarkets.com/stock/DECN/filings

I have compared the original and amended Management Discussions and the only change that I was able to find was the addition of the following paragraph:
"In addition, sales may be impacted negatively due to recent marketing efforts by Johnson & Johnson’s diabetic division Lifescan. Lifescan has made an effort to move their OneTouch Ultra market share to the Verio line of products. This includes extensive promotional efforts for the Verio meters, a supposed (threatened) withdrawal of support for Ultra products, and a decrease in the production, marketing, and availability of Ultra products. This was a successful strategy in Great Britain during 2Q 2017 and might be successful in the U.S. and Canada. However, given the spotty history of mass meter switchover programs, the company believes a significant number of users who “take the bait” and switch to the new Lifescan meter may be displeased with the cost of the new supplies. The company plans to implement educational promotions to educate the customer on the benefits of continued use of legacy Ultra meters."

There are numerous other things that could have been corrected in the numbers, some obvious mistakes in the calculations of percentage changes from the prior period for example, but the original Management Discussion was dumped solely in order to add the above paragraph.

I didn't compare the old and new Supplemental Information reports in their entirety so I don't know if any other changes were made there, but the paragraph was added in that report as well.


Obviously Mr. Berman thought that it was a very important change to make.